Silence Therapeutics (SLN) Net Margin: 2020-2025
Historic Net Margin for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to 13,181.13%.
- Silence Therapeutics' Net Margin fell 1080837.00% to 13,181.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 249.86%, marking a year-over-year increase of 20403.00%. This contributed to the annual value of 104.74% for FY2024, which is 6663.00% up from last year.
- As of Q3 2025, Silence Therapeutics' Net Margin stood at 13,181.13%, which was down 7.94% from 12,211.61% recorded in Q2 2025.
- Silence Therapeutics' 5-year Net Margin high stood at 48.61% for Q4 2024, and its period low was 20,091.55% during Q1 2025.
- In the last 3 years, Silence Therapeutics' Net Margin had a median value of 713.01% in 2023 and averaged 4,693.63%.
- In the last 5 years, Silence Therapeutics' Net Margin soared by 76,162bps in 2024 and then tumbled by 2,007,682bps in 2025.
- MRQ analysis of 5 years shows Silence Therapeutics' Net Margin stood at 328.85% in 2021, then increased by 4bps to 315.84% in 2022, then tumbled by 126bps to 713.01% in 2023, then soared by 107bps to 48.61% in 2024, then plummeted by 27,213bps to 13,181.13% in 2025.
- Its Net Margin was 13,181.13% in Q3 2025, compared to 12,211.61% in Q2 2025 and 20,091.55% in Q1 2025.